Charles Schwab Investment Management »

Revance Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.0M 677k 8.79
2023-09-30 $7.6M 664k 11.47
2023-06-30 $16M 627k 25.31
2023-03-31 $20M 607k 32.21
2022-12-31 $11M 607k 18.46
2022-09-30 $15M 569k 27.00
2022-06-30 $6.7M 482k 13.82
2022-03-31 $9.6M 492k 19.50
2021-12-31 $7.8M 477k 16.32
2021-09-30 $13M 471k 27.86
2021-06-30 $14M 468k 29.64
2021-03-31 $13M 447k 27.95
2020-12-31 $12M 411k 28.34
2020-09-30 $10M 406k 25.14
2020-06-30 $8.2M 336k 24.42
2020-03-31 $4.5M 305k 14.80
2019-12-31 $4.4M 269k 16.23
2019-09-30 $3.2M 245k 13.00
2019-06-30 $3.1M 243k 12.97
2019-03-31 $3.6M 225k 15.76
2018-12-31 $3.6M 177k 20.13
2018-09-30 $4.4M 178k 24.85
2018-06-30 $4.2M 153k 27.46
2018-03-31 $4.1M 135k 30.81
2017-12-31 $4.2M 118k 35.75
2017-09-30 $3.2M 117k 27.55
2017-06-30 $3.0M 112k 26.41
2017-03-31 $1.9M 93k 20.80
2016-12-31 $1.8M 89k 20.71
2016-09-30 $968k 60k 16.21
2016-06-30 $902k 66k 13.61
2016-03-31 $1.1M 65k 17.46
2015-12-31 $2.2M 64k 34.18
2015-09-30 $1.4M 47k 29.78
2015-06-30 $1.2M 36k 31.99
2015-03-31 $553k 27k 20.73
2014-12-31 $427k 25k 16.97
2014-09-30 $373k 19k 19.38
2014-06-30 $525k 15k 34.03